GMAB stock forecast for 2023 – 2027
Last updated: April 19, 2024
Are you interested in Genmab A/S stocks prediction? If yes, then on this page you will find useful information about the dynamics of the GMAB stock price in 2022-2027. Is GMAB a good long term stock? When should I take profit in Genmab stock? Buy or sell stock? Will GMAB stock price go up? What are analysts’ forecasts for GMAB stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. GMAB stock returns are also predicted based on historical data.
According to our research, GMAB stock is a bad long-term investment. GMAB share price has been in a bear cycle for the past year. Genmab A/S stock trend is negative.
Genmab company info
| Industry | Biotechnology |
| Address | Kalvebod Brygge 43, Copenhagen, 1560, Denmark |
| Website | https://www.genmab.com |
Forecasting
52 Week High: 36.1916 USD
52 Week Low: 24.526 USD
1 Year Forecast: 28.7082 USD
5 Year Forecast: 0 USD
Agilent Technologies info
Market Cap: 22.34B
52 Week Change: -6.498%
52 Week High: 49.07 USD
52 Week Low: 30.1 USD
Beta: 0.989088
50 Day Moving Average: 37.12
90 Day Moving Average: 38.548
200 Day Moving Average: 42.4
Resistance Level: 35.7663
Pivot Point: 33.2857
Support Level: 33.6396
Enterprise Value: 32,148,652,032
Forward P/E: 4.13
Forward EPS: 7.96
Profit Margin: 36.34%
Shares Outstanding: 654,193,024
EBITDA: 9.41
Held Percent Institutions: 7.19%
PEG Ratio (5Y): 0.24
Trailing EPS: 0.66
Genmab stock forecasts for 2023-2027
| Date | Open Price | Close Price | Change |
Genmab Stock Forecast for 2023 | |||
| January 2023 | 29.58 | 27.44 | -7.23% |
| February 2023 | 28.56 | 24 | -15.97% |
| March 2023 | 24.48 | 19.6 | -19.93% |
| April 2023 | 20.79 | 22.54 | 8.42% |
| May 2023 | 23.23 | 27 | 16.23% |
| June 2023 | 27.54 | 28 | 1.67% |
| July 2023 | 27.72 | 29.29 | 5.66% |
| August 2023 | 29.58 | 30.3 | 2.43% |
| September 2023 | 30 | 28.28 | -5.73% |
| October 2023 | 28 | 27 | -3.57% |
| November 2023 | 28 | 25 | -10.71% |
| December 2023 | 24.5 | 25 | 2.04% |
Genmab Stock Forecast for 2024 | |||
| January 2024 | 24.75 | 23.76 | -4% |
| February 2024 | 24 | 20 | -16.67% |
| March 2024 | 20 | 16.16 | -19.2% |
| April 2024 | 15.68 | 18.62 | 18.75% |
| May 2024 | 18.81 | 22.77 | 21.05% |
| June 2024 | 23.23 | 24 | 3.31% |
| July 2024 | 24 | 25.25 | 5.21% |
| August 2024 | 25.5 | 25.48 | -0.08% |
| September 2024 | 26.52 | 23.23 | -12.41% |
| October 2024 | 22.77 | 22.77 | 0% |
| November 2024 | 22.54 | 21.21 | -5.9% |
| December 2024 | 21 | 20.4 | -2.86% |
Genmab Stock Forecast for 2025 | |||
| January 2025 | 20 | 19.6 | -2% |
| February 2025 | 19.6 | 16 | -18.37% |
| March 2025 | 14.85 | 11.76 | -20.81% |
| April 2025 | 12 | 15 | 25% |
| May 2025 | 15 | 18 | 20% |
| June 2025 | 19 | 19.8 | 4.21% |
| July 2025 | 19.8 | 21 | 6.06% |
| August 2025 | 21.42 | 21.78 | 1.68% |
| September 2025 | 21.56 | 19.38 | -10.11% |
| October 2025 | 19.38 | 18.81 | -2.94% |
| November 2025 | 19.19 | 16.83 | -12.3% |
| December 2025 | 16.16 | 15.68 | -2.97% |
Genmab Stock Forecast for 2026 | |||
| January 2026 | 16.16 | 14.85 | -8.11% |
| February 2026 | 14.85 | 11.76 | -20.81% |
| March 2026 | 10.89 | 8.08 | -25.8% |
| April 2026 | 7.84 | 11.22 | 43.11% |
| May 2026 | 10.78 | 13.72 | 27.27% |
| June 2026 | 14 | 14.85 | 6.07% |
| July 2026 | 15.68 | 17 | 8.42% |
| August 2026 | 16.66 | 18.36 | 10.2% |
| September 2026 | 17.17 | 15 | -12.64% |
| October 2026 | 15.3 | 14.7 | -3.92% |
| November 2026 | 15 | 12 | -20% |
| December 2026 | 12.12 | 12.12 | 0% |
Genmab Stock Forecast for 2027 | |||
| January 2027 | 11.76 | 11.11 | -5.53% |